NCT01441973 Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma Status COMPLETED Phase PHASE2
NCT01439204 Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb Status COMPLETED Phase PHASE1
NCT01438424 Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials Status COMPLETED Phase PHASE2
NCT01437787 Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis Status COMPLETED Phase PHASE3
NCT01434186 A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone Status COMPLETED Phase PHASE3
NCT01428063 Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials Status COMPLETED Phase PHASE2
NCT01425970 Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin Status TERMINATED Phase PHASE2
NCT01423695 Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01420783 Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia Status COMPLETED Phase PHASE2
NCT01413906 Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT01412866 Electronic Decision Support Systems for Smokers With Severe Mental Illness Status COMPLETED Phase NA
NCT01411930 Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics Status COMPLETED Phase PHASE4
NCT01409174 IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma Status TERMINATED Phase PHASE1
NCT01404585 Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01404572 Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01400451 Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) Status TERMINATED Phase PHASE1
NCT01394666 Non-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML) Status COMPLETED Phase N/A
NCT01393964 Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function Status COMPLETED Phase PHASE1